Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis

BACKGROUND: The use of monotherapy with intensive granulocyte and monocyte adsorptive apheresis (GMA) or a Janus kinase (JAK) inhibitor has been limited to patients with refractory ulcerative colitis (UC). The efficacy and safety of combination therapy with tofacitinib (TOF) plus intensive GMA (two...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Med Res
Päätekijät: Tanida, Satoshi, Ozeki, Keiji, Mizoshita, Tsutomu, Kitagawa, Mika, Ozeki, Takanori, Tanaka, Mamoru, Nishie, Hirotada, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elmer Press 2020
Aiheet:
Short Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6968921/
https://ncbi.nlm.nih.gov/pubmed/32010420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4037
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia